ReviewAllergologie select2024

Regulatory framework for development and marketing authorization of allergen products for diagnosis of rare type I and type IV allergies: The current status.

Julia Zimmer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.